[1]

  • M.L.G. Borst, C.M.J. Ouairy, S.C. Fokkema, A. Cecchi, J.M.C.A. Kerckhoffs, V.L. de Boer, P.J. van den Boogaard, R.F. Bus, R. Ebens, R. van der Hulst, J. Knol, R. Libbers, Z.M. Lion, B.W. Settels, E. de Wever, K.A. Attia, P. Sinnema, J.M. de Gooijer, K. Harkema, M. Hazewinkel, S. Snijder, and K. Pouwer, "Polycyclic Sulfoximines as New Scaffolds for Drug Discovery", ACS Combinatorial Science, vol. 20, pp. 335-343, 2018. http://dx.doi.org/10.1021/acscombsci.7b00150

  • [1]

  • G. Németh, Z. Greff, A. Sipos, Z. Varga, R. Székely, M. Sebestyén, Z. Jászay, S. Béni, Z. Nemes, J. Pirat, J. Volle, D. Virieux, . Gyuris, K. Kelemenics, . Áy, J. Minarovits, S. Szathmary, G. Kéri, and L. Őrfi, "Synthesis and Evaluation of Phosphorus Containing, Specific CDK9/CycT1 Inhibitors", Journal of Medicinal Chemistry, vol. 57, pp. 3939-3965, 2014. http://dx.doi.org/10.1021/jm401742r
  • a rare example of cpvament drug acting by SNAr mechanism:

    [1]

  • Q. Zeng, A.G. Nair, S.B. Rosenblum, H. Huang, C.A. Lesburg, Y. Jiang, O. Selyutin, T. Chan, F. Bennett, K.X. Chen, S. Venkatraman, M. Sannigrahi, F. Velazquez, J.S. Duca, S. Gavalas, Y. Huang, H. Pu, L. Wang, P. Pinto, B. Vibulbhan, S. Agrawal, E. Ferrari, C. Jiang, C. Li, D. Hesk, J. Gesell, S. Sorota, N. Shih, F.G. Njoroge, and J.A. Kozlowski, "Discovery of an irreversible HCV NS5B polymerase inhibitor", Bioorganic & Medicinal Chemistry Letters, vol. 23, pp. 6585-6587, 2013. http://dx.doi.org/10.1016/j.bmcl.2013.10.060